The spinal cord injury community is integral to technology innovation
Paul Amadeus Lane of the United Spinal Association discusses digital transformation and how virtual rehab, AI and machine learning can enhance quality of life.
...
Zoledronic acid provides protection against bone loss after acute spinal cord injury
An annual infusion of zoledronic acid can help attenuate bone loss in adults with acute spinal cord injury, according to a study published in...
FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with...
NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA)...
United Spinal Launches ‘Voices United’ Campaign To Highlight The Positive Impact Of People With...
United Spinal Association recently launched its 'Voices United' campaign to amplify the strengths and talents of its membership community as the organization celebrates its...
‘Zombie cells’ hold clues to spinal cord injury repair
Mammals have a poor ability to recover after a spinal cord injury which can result in paralysis. A main reason for this is the...
More than half of wheelchair users with spinal cord injury needed repairs in past...
Vulnerable populations are most likely to experience negative consequences of wheelchair breakdown, such as missing work or school or being stranded outside the home
East...
Keio University to test use of iPS cells to treat spinal cord injuries
The Yomiuri ShimbunKeio University has begun a clinical study to treat patients with spinal cord injuries using induced pluripotent stem (iPS) cells, The Yomiuri...
Brain-Computer Interface Enables Johns Hopkins Study Participant to Touch and Feel Holographic Objects
As part of a larger study exploring neural multiplexing and new modes of perception enabled by brain-computer interface (BCI), Johns Hopkins researchers have demonstrated...
A New microRNA Target for Treating Spinal Cord Injuries
WASHINGTON, June 9, 2021 /PRNewswire/ -- An article published in Experimental Biology and Medicine (Volume 246, Issue 11, June 2021) describes a new target for treating...
Introducing accessFind
My name is Josh Basile, and I am a 35-year-old disability rights advocate, lawyer, mentor, adventure seeker, and C4-5 quadriplegic. My life was flipped...
